19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

NCT04464200 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma
Primary Mediastinal Large B Cell Lymphoma
Transformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma
Chronic Lymphocytic Leukemia
Indolent Non-Hodgkin Lymphoma
Marginal Zone Lymphoma
Waldenstrom Macroglobulinemia
Burkitt's Lymphoma
Primary CNS Lymphoma

Interventions

DRUG: 19(T2)28z1xx CAR T cells

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]